Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pure anti-oestrogens.

C Hermenegildo1, A Cano

  • 1Dept. Pediatrics, Obstetrics and Gynecology, Faculty of Medicine and Dentistry, University of Valencia, Spain. hermenel@post.uv.es

Human Reproduction Update
|June 30, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluation of an experimental model of senescence SAMR1/SAMP8 for microRNA studies in acute myocardial infarction: role of sex and aging.

Journal of physiology and biochemistry·2026
Same author

Chemical composition and radionuclide activity concentration data in cements, SCMs, aggregates, ceramics and other materials that could be valorised in construction materials.

Data in brief·2026
Same author

Erratum: Addendum: A novel estimate of biological aging by multiple fitness tests is associated with risk scores for age-related diseases.

Frontiers in physiology·2026
Same author

Deletion of <i>C2orf34</i>, <i>PREPL</i> and <i>SLC3A1</i> causes atypical hypotonia-cystinuria syndrome.

BMJ case reports·2025
Same author

Capping Effects on Spin and Charge Excitations in Parent and Superconducting Nd_{1-x}Sr_{x}NiO_{2}.

Physical review letters·2024
Same author

Allelic variants of the estrogen receptor genes and frailty phenotype in postmenopausal women.

Climacteric : the journal of the International Menopause Society·2024
Same journal

Clinical outcomes and euploidy rates of embryos derived from zygotes with nonpronuclear (0PN) and monopronuclear (1PN) in IVF or ICSI cycles: a systematic review and meta-analysis.

Human reproduction update·2026
Same journal

Sperm mitochondrial DNA copy number: a marker of male fertility and reproductive success.

Human reproduction update·2026
Same journal

Embryo-derived extracellular vesicles and their potential as biomarkers for embryo quality during IVF: a systematic review.

Human reproduction update·2026
Same journal

Endometriosis and ovarian cancer: epidemiological evidence, molecular insights, and clinical decision-making.

Human reproduction update·2026
Same journal

Maternal genetic variants associated with aneuploid conception: a narrative review.

Human reproduction update·2026
Same journal

Iron overload disorders in adults: a comprehensive review of gonadal function, reproductive, and sexual health.

Human reproduction update·2026
See all related articles

Pure anti-estrogens offer a promising alternative to tamoxifen for treating breast cancer and gynecological diseases. These compounds effectively block estrogen

Area of Science:

  • Endocrinology
  • Oncology
  • Pharmacology

Background:

  • Estrogen plays a crucial role in various physiological processes and diseases, including breast cancer.
  • Pure anti-estrogens are a class of compounds that antagonize estrogen's effects.
  • Tamoxifen is a widely used anti-estrogen, but resistance can develop.

Purpose of the Study:

  • To investigate the mechanism of action of pure anti-estrogens.
  • To evaluate the efficacy of pure anti-estrogens in preclinical and clinical settings.
  • To explore their potential as alternatives to tamoxifen in breast cancer and gynecological diseases.

Main Methods:

  • In vitro studies on breast cancer cell lines.
  • In vivo studies in animal models.

Related Experiment Videos

  • Preliminary clinical trials with ICI 182780 and ongoing trials with EM-800.

    • Main Results:

    • Pure anti-estrogens act as competitive antagonists of estrogen receptors.
    • They inhibit estrogen-stimulated growth of breast cancer cells in vitro.
    • Demonstrated efficacy in blocking estrogen's effects on reproductive-associated tissues in animals.
    • Preliminary clinical trials show promising results in tamoxifen-resistant breast cancer.

    Conclusions:

    • Pure anti-estrogens represent a novel therapeutic strategy.
    • They show potential as effective alternatives to tamoxifen for breast cancer treatment.
    • Further investigation is warranted for their use in non-malignant gynecological diseases.